Reckitt Benckiser, the global consumer healthcare and home products giant, has appointed three new creative agencies to its global agency roster after a review that began late last year initially for brands Clearasil, Air Wick and Finish.
The company expanded the review to include Mucinex and Delsym. The company spends an estimated $100 million on ads collectively for the brands that were
Droga 5 New York has been appointed to lead creative development on Air Wick and Clearasil globally.
Wieden+Kennedy has been appointed to lead creative development on Finish globally.
And Interpublic’s McCann has been appointed to lead creative development on Mucinex and Delsym.
Havas WW was the incumbent and defended. RB said that Havas WW “continues to be a key agency partner and retains the rest of the extensive brand portfolio.”
Heather Allen, executive vice president global category development at RB said, "The quality of the strategic and creative thinking we have seen throughout the review has been superb… Creativity is at the heart of our growth strategy and we are very confident that we have the right partners to grow our brands.”
The review was managed by Agency Assessments International.
Last year RB conducted a media review for its U.S. assignment and selected Aegis Media over incumbent ZenithOptimedia, which still handles duties for markets outside the U.S.